Combination CurQD and Vedolizumab in Ulcerative Colitis

NCT07665294 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: CurQD
DRUG: Placebo
DRUG: Vedolizumab

Sponsor

Ryan C Ungaro

Collaborators

[object Object]